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Abstract 
Pan-microbial inactivation technologies that do not require high temperatures, reactive chemical 
compounds, or UV radiation could address gaps in current infection control strategies and provide efficient 
sterilization of biologics in the biotechnological industry. Here, we demonstrate that femtosecond (fs) 
laser irradiation of resonant gold nanoparticles (NPs) under conditions that allow for E-field mediated 
cavitation and shockwave generation achieve an efficient plasmon-enhanced photonic microbial pathogen 
inactivation. We demonstrate that this NP-enhanced, physical inactivation approach is effective against a 
diverse group of pathogens, including both enveloped and non-enveloped viruses, and a variety of bacteria 
and mycoplasma. Photonic inactivation is wavelength-dependent and in the absence of plasmonic 
enhancement from NPs, negligible levels of microbial inactivation are observed in the near-infrared (NIR) 
at 800 nm. This changes upon addition of resonant plasmonic NPs, which provide a strong enhancement 
of inactivation of viral and bacterial contaminants. Importantly, the plasmon-enhanced 800 nm 
femtosecond (fs)-pulse induced inactivation was selective to pathogens. No measurable damage was 
observed for antibodies included as representative biologics under identical conditions.  
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Introduction 
The alarming growth of antibiotic resistances and hospital associated microbial infections is driving an 
urgent general need for alternative microbial inactivation strategies in the entire health care sector.  
Although less publicized than the challenges associated with treating human infections with resistant 
pathogens, the need for new pathogen inactivation strategies also applies to key sectors of biotechnology 
that rely on mammalian cell and tissue culturing. Of particular importance to the pharmaceutical industry 
sector is the need to safely produce biologics, which are one of the fastest growing classes of 
pharmaceuticals with high direct relevance for human health. Some biologics, such as monoclonal 
antibodies (MABs), are fabricated with living mammalian cells, rendering them particularly vulnerable to 
contaminations by microbes and pathogens. Microbial contaminations cause changes in the composition 
of the bioreactor used to manufacture biologics, potentially inducing a loss in the potency due to 
degradation, and can by themselves be harmful for human health. Aseptic processing of a 
biopharmaceutical process is often insufficient, so a terminal sterilization for biologics is mandatory (1-
3). Since microbe inactivation through high temperatures, UV irradiation or aggressive chemicals risk a 
deactivation of the precious biologics, alternative inactivation and removal strategies of viruses (4), 
mycoplasma (5), and bacteria (6) are needed in the pharmaceutical industry. The current best practice for 
final viral clearance is passive filtration (7). Filtration is also the preferred method to remove bacterial 
contaminations, including mycoplasma. The latter are small bacteria that lack a cell wall (8). Mycoplasma 
are not only detrimental to human health, with some species being pathogenic (9), but they are also 
widespread contaminants of cell culture (10). A key challenge for viral and mycoplasma clearance of cell 
culture by filtration is the small size of the organisms. Mycoplasma can pass through 200 nm filter pores 
and the filter size requirements are even more stringent for viruses. For instance, parvovirus is a truly 
nanoscale object with a characteristic diameter between 18-26 nm (11). These very small sizes pose 
significant challenges for a reliable removal of pathogen contaminants with conventional nanofiltration 
devices. To trap viruses as small as parvovirus, the pore size, Rp, needs to be in the range between 10-18 
nm. Pores of these small dimensions create significant challenges for filtering at an industrial scale. Since 
the Poiseuille flow rate scales as ~ 1/Rp4 for a fixed pressure drop (12), either the flow rate necessarily has 
to be small, or significantly higher pressure differences exceeding 0.5 MPa have to be applied to retain 
sufficient flow rates through the filter for liter-scale production. In practice, these requirements make 
microbe filtration very expensive and difficult to implement in large scale bioreactor systems. Although 
cell wall containing bacteria are generally larger than mycoplasma and can be effectively removed by 
filtration, filter membranes in general have limited capacity, require frequent exchange, and represent 
potential sources of contamination.  
A potential alternative to filtration that has recently attracted interest is sterilization with pulsed laser 
sources. The groups of Tsen and Achilefu have shown that femtosecond (fs) lasers can inactivate 
enveloped viruses, non-enveloped viruses, bacteria, and yeast in a label-free manner (13). The authors 
argued that virus inactivation was primarily due to impulsive stimulated Raman scattering, although this 
interpretation has been challenged (14). Limitations of the conventional pulsed laser pathogen inactivation 
method include the requirement for long exposure times that limit the scalability of the approach and the 
predominant use of near-UV lasers. In the published studies (15, 16), samples were typically irradiated 
for ≥1 hour with fs laser pulses at a wavelength of λ= 415±5 nm.  A significant concern associated with 
exposing biological samples to short wavelength radiation, especially pulsed laser radiation, is that photon 
energies overlap with electronic transitions in biomolecules (DNA, RNA, proteins). Absorption of short 
wavelength photons can therefore trigger photo-induced chemical reactions and radical formation, 
resulting in a loss of selectivity for pathogens and in collateral damage for biologics (17). These UV-
absorption driven mechanisms could play a significant role in the previously observed virus inactivation. 
One possible strategy to avoid this complication is to operate at longer wavelengths that do not pose the 
same risks to biologics. Operation in the near-infrared (NIR) is desirable due to greatly reduced molecular 
absorption, and photonic virus inactivation in the NIR has indeed been successfully demonstrated, but 
unfortunately the need for long exposure times which limits the scalability of this technique has remained 
(18). There has recently been significant interest in the nanoscale plasma generation around plasmonic 
NPs (19-21), and it was shown that under fs-pulsed laser irradiation the intense field surrounding 
plasmonic NPs can induce cavitation and result in the formation of hydrodynamic shockwaves. We 
discovered that the photonic inactivation of membrane-wrapped murine leukemia virus (MLV) using 
pulsed NIR lasers can be drastically improved if the virus is irradiated in the presence of NPs in the regime 
of shockwave generation (22). We demonstrated that the ultrashort pulsed laser technology facilitates a 
rapid and effective inactivation of viruses in the presence of plasmonic NPs. Importantly, the plasmon-
enhanced inactivation did not require binding of the NPs to the viral pathogens and was selective to the 
virus and did not induce any measurable damage to co-incubated antibodies (22). As real-world samples 
risk contamination by a wide range of potential microbes, including enveloped and non-enveloped viruses, 
as well as gram-positive or gram-negative bacteria and mollicute bacteria (i.e. mycoplasma), it remains a 
high priority to develop efficient inactivation strategies that can reliably inactivate biologically-diverse 
pathogens. NPs of different chemical composition provide opportunities for the development of new 
antimicrobial strategies with potentially pan-microbial efficacy (23-29). In this work, we focus on the 
photonic inactivation of pathogens enhanced by resonant gold NPs and test the efficacy of the plasmon-
enhanced photonic inactivation strategy against a diverse group of microbial pathogens. We demonstrate 
that plasmonic enhancement of photonic inactivation is successful in eliminating non-enveloped viruses 
(bacteriophage fX174), mollicute bacteria (Acholeplasma laidlawii), as well as gram-negative 
(Escherichia coli) and gram-positive bacteria (Bacillus subtilis). Importantly, the plasmonic enhancement 
facilitates a reduction in illumination time at 800 nm, which paves the path to a broadband photon-driven 
pathogen inactivation strategy that is fast, selective and works under ambient conditions.  
 
Results and Discussion 
To demonstrate the efficacy of plasmonic enhancement of photonic inactivation of pathogens, we chose 
an operational wavelength in the NIR (800 nm). We chose this wavelength region as linear electronic or 
vibrational absorption cross-sections of biomolecules are small, and direct lowest order interactions 
between photons and biological matter is therefore minimal. A variety of nonlinear multiphoton processes 
can occur. Two-photon processes (30), for instance, include primarily the electronic excitation of heme in 
proteins such as cytochrome C with a cross-section of < 1 GM (= 10-50 cm4 s molecules-1 photon-1) (31). 
The subsequent rapid non-radiative relaxation leads to heating of < 1 K at the concentration of 
cytochromes expected. At 800 nm, three-photon processes can in principle excite electronic transitions in 
DNA or in water, but the cross-sections are too low for 3-photon pathogen inactivation. Raman and 
inelastic processes can result in transfer of energy but the cross-sections of ~ 10-31 cm2 at 800 nm are too 
low for concern. Resonance Raman processes can generally be neglected at the fundamental 800 nm. The 
magnitudes of the electric fields in the laser are below the dielectric breakdown in water (32). In summary, 
effects attributed to direct molecular absorption at 800 nm are too small to account for the observed 
pathogen inactivation. In contrast, gold NPs can sustain strong plasmon resonances in the NIR. Our 
experimental strategy is to utilize the resonant excitation of localized plasmon resonances to generate 
intense local fields around the NPs that initiate cavitation and subsequent shockwave generation under 
high power pulsed laser irradiation (32). Specifically, we used two different NP geometries with localized 
surface plasmon resonances (LSPRs) at or close to 800 nm in this work: nanorods (NRs) with an aspect 
ratio of around 4 and typical lengths of ~60 nm, and bipyramids with a length of 81.7 ± 1.6 nm, width 
of 27.5 ± 0.6 nm and tip radius of ~ 4 nm. The advantage of the gold bipyramids is that they can be 
generated with less structural variability on the ensemble level, which leads to sharper initial LSPR spectra 
(33). As the intense pulsed fs-laser irradiation induces a surface melting of the bipyramids, we 
characterized the morphological changes to determine the optimal operational conditions. To that end, we 
irradiated bipyramids with 800 nm laser pulses with 35 fs duration and 3W average power for different 
time durations: 10 s, 1 min, 10 min and 30 min. We recorded UV-Vis spectra and TEM images after laser 
irradiation. Figure 1 illustrates the gradual conversion of bipyramids into spheres. The structural 
reshaping is associated with a loss in oscillator strength and broadening for the longitudinal plasmon mode 
at 800 nm, while the increase at 520 nm (slightly red-shifted from the vertical mode of the bipyramids) 
results from an increase in spheroidal particles. Since the plasmon-mediated enhancement of photonic 
pathogen inactivation is a resonant effect (22), and the LSPR wavelength of the generated spherical gold 
NPs does not overlap with the preferred pump wavelength of 800 nm, we limited the maximum exposure 
time in this work to 20 min for Bacillus subtilis (B. subtilis) or 30 min for Acholeplasma laidlawii (A. 
laidlawii) and Escherichia coli (E. coli). We used both NRs and bipyramids in a ratio of approximately 
100:1 (NP: pathogen) in this work and did not detect a significant difference in pathogen inactivation 
between the two forms of plasmonic resonators. 
 
Wavelength dependence of Photonic Inactivation of Bacteriaphage, fX174. A previous study 
demonstrated the fundamental feasibility of a plasmonic enhancement of pulsed laser photonic 
inactivation of viral pathogens, but that work was limited to the enveloped virus MLV (22). To confirm a 
broader relevance and, in particular, to demonstrate the efficacy of plasmon-enhanced photonic 
inactivation of viruses that are not membrane-wrapped and therefore more robust, we studied inactivation 
of the bacteriophage fX174, which is arguably one of the most robust virus species (34). We first 
determined the log-reduction value (LRV) of batch mode processing for a solution containing 2 mL of 
fX174 in the absence of gold NPs using either the fundamental (~800 nm) output or the frequency doubled 
(~400 nm) output in batch mode (Figure 2A). Previous studies utilizing 100 fs near-UV (415 nm) pulses, 
reported effective viral inactivation (Figure 2B) for power densities greater than ~20 MW/cm2 (35), and 
we achieved a reproducible reduction in fX174 concentration using frequency-doubled 400 nm fs laser 
pulses with just 1 min of exposure (36). In contrast, at 800 nm we found only modest LRV after 15 min 
exposure to 35 fs long pulses with power densities beyond 100 GW/cm2 and remarkably almost into the 
TW/cm2 scale. Even longer exposure times of up to 120 min with 800 nm pulses did not achieve a 
substantial improvement of fX174 inactivation. Importantly, a comparison of LRV obtained at 
fundamental (red) and frequency doubled (blue) wavelengths for different irradiation times (Figure 2C) 
shows that the long wavelength has a much smaller effect. This finding resolves one part of the contention 
in the published literature (14). Our results demonstrate that 800 nm ultrashort laser pulses – even at 
GW/cm2 power densities – do not provide a sufficiently strong effect to inactivate viruses. Turning to the 
effect of frequency-doubled ~400 nm centered laser pulses, however, short exposures of less than 1 min 
are sufficient to inactivate viruses to a point where it is difficult to detect virus at all in initial titers of ~ 
106 plaque forming units (pfu)/mL. We subsequently performed experiments at still higher initial titer 
ranging up to 109 pfu/mL. The higher titer allowed for a greater dynamic range in the virus inactivation 
assays. Under these conditions laser exposure studies indicate an LRV of greater than 6 was recorded 
(Figure 2C), exceeding the industry guidelines of LRV > 4 for effective viral inactivation.  
 
Photonic Inactivation of fX174 in Flow-through Mode. A current bottleneck of photonic inactivation 
strategies is insufficient experimental throughput. One possible strategy to treat larger volumes of cell 
medium is based on a flow-through approach in which a continuous flow passes through the laser beam 
(Figure 3A), allowing to avoid any wait times or process interruptions. Figure 3B shows the results of 
femtosecond laser inactivation of fX174 with 109 pfu/mL using frequency doubled femtosecond laser 
pulses as well as of controls. In the flow-through mode geometry, a solution containing 2 mL of fX174 
virus is continuously pumped with a flow rate of 2 mL/h through a 2 mm cuvette at an effective filtrate 
flux of 111 L/h/m2. The cuvette is irradiated with frequency-doubled 400 nm pulsed laser irradiation. The 
experiments do not involve stirring and the flow rates were sufficiently slow to ensure laminar flow 
throughout the experiment. Our measurements yield more than 5.8 LRV reduction in the laser exposed 
samples. Controls include samples with no laser exposure held in the refrigerator and “No Laser” sample 
that experienced the same experimental condition as the rum sample but without laser irradiation. 
Importantly, both of these controls did not show virus inactivation, with an upper limit on the LRV that is 
nearly 5 orders of magnitude smaller than with the laser on. We also determined LRV of laser irradiated 
virus sample without freezing the virus after the laser exposure but before the plaque assay. These 
measurements yielded LRV of ~ 6, which suggests that the freeze-thaw cycle of the sample after each 
experiment does not significantly damage the virus. The robust inactivation in the flow-through mode by 
frequency-doubled femtosecond near-UV laser pulses confirms the results obtained in the batch mode. To 
check for scalability of the flow-through technique, the total volume of the sample was varied from 2 mL 
to 5 mL with a constant flow rate of 2 mL/h. For all of these samples similar laser-dependent reductions 
in infectivity were observed.  
 
Plasmonic Enhancement of fX174 Inactivation. The lack of a significant reduction in viral load with 
800 nm fs-pulsed laser irradiation (Figure 2C) is indicative of a greatly reduced propensity for photo-
damage through single photon absorption processes in the IR. The fact that only pulsed 400 nm but not 
800 nm light achieves a measurable inactivation of fX174 limits the applicability and usefulness of the 
conventional photonic virus inactivation strategy as significant collateral damage on precious molecules 
and biologics in the solution can be expected for an operational wavelength in the near-UV. At 800 nm, 
the risk of collateral damage is much lower (22) as linear electronic or vibrational absorption cross-
sections of biomolecules are negligible and direct lowest order interactions between photons and 
biological matter is at a minimum. Three-photon processes could in principle excite electronic transitions 
in DNA or in water, but the cross-sections are exceedingly low. Furthermore, Raman and inelastic 
processes can result in transfer of energy, but the cross-sections of ~ 10-31 cm2 at 800 nm are still too low 
for concern. Resonance Raman processes can generally be neglected at the 800 nm fundamental due to a 
lack of accessible electronic excited states at this energy. In summary, effects attributed to molecular 
absorption at 800 nm are too small to account for an efficient pathogen inactivation. The challenge is, 
thus, to develop enhancement strategies that allow a selective photonic inactivation of the targeted 
pathogens under NIR irradiation and that can simultaneously take advantage of the overall low collateral 
damage at long wavelengths. While intrinsic molecular absorption is weak in the NIR, metal NPs have 
shape-tunable optical cross-section and can provide absorption optical cross-sections of ~10-10 cm2 at 800 
nm (37). Importantly, although the electric field intensities of the laser used in this study are below the 
threshold for dielectric breakdown in water (32), this changes in the presence of plasmonic nanoantennas 
that can focus the incident light power into nanoscale “hot-spots”. Photonic excitation of surface plasmons 
in NPs exhibit an extraordinarily rich variety of phenomena. Depending on the pulse width, intensity and 
center frequency, reported effects range from photothermal effects, nonlinear photonic effects, and release 
of reactive oxygen species, among others (21, 38).   Photoacoustic signals  detected  in previous studies 
on plasmon-enhanced inactivation of viruses using femtosecond lasers are consistent with a plasmonic 
cavitation induced shockwave as potential mechanism of MLV viral inactivation (22). To evaluate 
whether the same mechanisms applied to other, non-enveloped viruses, we tested the effect of gold NRs 
on the inactivation of fX174 at 800 nm in a flow-through geometry with a flow rate of 2 mL/h. 
Intriguingly, when we irradiated fX174 with initial titer of 109 pfu/mL and a sample volume of 1.5 mL at 
800 nm with 3W laser power in the presence of resonant gold NRs or bipyramids, we obtained a very 
impressive LRV of > 7 (Figure 3C). A control without gold NRs achieved only a LRV of ~1.3 under 
identical conditions. We mention in passing that when we increased the flow to 100 mL/h, corresponding 
to a reduction in the laser exposure time to less than 1 min, the measured LRV in the presence of the NRs 
dropped to 2.9, confirming that the inactivation observed with the NRs is a photonic effect. 
 
800 nm Laser Irradiation Does Not Result in Protein Collateral Damage. To assess the effect of pulsed 
fs irradiation on the functionality of proteins, we exposed the monoclonal antibody at high concentration 
of ~38 mg/mL to 800 nm fs radiation and frequency-doubled 400 nm laser pulses for 10 s, 1 min and 5 
min and analyzed structural changes to a monoclonal antibody induced fs-irradiation in batch mode 
(Figure 4). Changes in the cation exchange and size exclusion chromatography of the antibody after 
irradiation at 400 nm indicate structural modifications in this case. Importantly, no evidence for structural 
changes or agglomeration or UV-Vis absorption spectrum change were observed for samples irradiated at 
800 nm. These data, together with the previous finding that pulsed 800 nm irradiation does not reduce 
antibody binding to its epitope in the presence of NRs (22) demonstrate an exquisite selectivity of the 
plasmon-enhanced inactivation process at a wavelength of 800 nm that selectively inactivates virus but 
does not damage antibodies.  
 
Plasmonic Enhancement of Photonic Inactivation of Bacteria and Mycoplasma. Conventional 
photonic inactivation has been primarily investigated with different virus species as target pathogens. Only 
a few studies have investigated the feasibility of de-activating bacterial pathogens, such as E. coli, S. typhi, 
L. monocytogenes and, E. sakazakii (16, 39).  Lu et al. (40) report that E. coli bacteria could be inactivated 
by up to 3 LRV through irradiation with ultrashort 415 nm light pulses using a laser power density of 
3.5 GW/cm2 for 1 h. The authors attributed the inactivation to the density dependent protein aggregation 
induced by the visible pulsed laser irradiation (40). Tsen et al. (13) found that gram-negative bacteria such 
as E. coli and S. typhimurium and gram-positive bacteria such as Listeria could be inactivated by LRV of 
2.4, 3.1, and 2.4 , respectively, upon irradiation with a 100 fs laser working at 415±5 nm for 1.5 h. 
Furthermore, until today there has only been a very limited number of studies into the photonic 
inactivation of mycoplasma with ultrafast lasers. Tsen et al. (15) focused on A. laidlawii and M. orale for 
which they demonstrated a reduction in viability through pulsed laser irradiation of only ~2 LRV. Overall, 
the level of inactivation obtained for bacteria and mycoplasma with photonic inactivation strategies 
remains insufficient for clearance purposes and motivates the development of improved enhancement 
strategies for these pathogens. 
We first evaluated whether the photonic inactivation of mycoplasma can be plasmonically enhanced. We 
chose mycoplasma A. laidlawii for these studies since it is one of the most frequent culture contaminations 
for cell and tissue cultures (41). We exposed A. laidlawii (~2x109 CFU/mL) for 30 min with 35 fs 800 nm 
pulses and frequency doubled 400 nm radiation in the presence of concanavalinA functionalized NRs and 
PEGylated NRs. ConcanavalinA is a 26.5 kDa lectin that recognizes α-D-mannosyl and α-D-glucosyl 
groups of glycoproteins and glycolipids. 800 nm irradiation without plasmonic enhancement did not yield 
a significant mycoplasma inactivation but frequency doubled 400 nm irradiation achieved a LRV of 2.8 
(Figure 5A). Intriguingly, addition of ConcanavalinA functionalized NR that can bind to the mycoplasma 
(42) did not yield any measurable enhancement of the inactivation, whereas resonant PEGylated NRs in 
solution yielded an impressive LRV = 6.7 (complete kill) (Figure 5B). Resonant NRs successfully 
amplified the photonic inactivation of A. laidlawii. These intriguing findings underline the applicability 
of the plasmonic inactivation enhancement approach for a diverse groups of pathogen species. The 
difference +/- ConcanavalinA suggests that the surface properties of the NPs and the interface between 
metal and the solution affect the inactivation process. This striking difference may arise if the surface-
bound protein interferes with an effective plasmonic shockwave generation around the NP by altering the 
threshold for cavitation and shockwave generation in the surface layer of water. More information into 
the mechanisms of plasmonic shockwave generation and the role of the metal/solution interface in 
modulating the threshold of shockwave formation are needed to test this hypothesis in the future. It is, 
however, clear that alternative inactivation mechanisms, such as the release of reactive oxygen species or 
competing proximal photothermal effects, would be enhanced by direct covalent linkage between the NPs 
and the pathogen.  
Mycoplasma differ from other gram-negetive and gram-positive bacteria through the lack of a cell wall. 
The absence of a cell wall and the associated structural flexibility complicates removal of mycoplasma 
through filtration but, at the same time, may make this bacteria genus more susceptible to shockwaves 
generated through pulsed laser excitation of resonant gold NPs. In the next step, we therefore tested the 
hypothesis that fs laser irradiation in the presence of gold NPs can boost the inactivation of gram-negative 
(E. coli) and gram-positive (B. subtilis) bacteria. Based on our observation that targeting functionalities 
bound to the NP deteriorate the inactivation of mycoplasma, we limited our analysis to bacteria co-
incubated with PEGylated NRs. We found for both species a significant inactivation enhancement in the 
presence of NRs. The measured LRV for B. subtilis (~109 CFU/mL) in Figure 6A was 3.4, which 
compares with -0.25 for 20 min 35 fs-laser irradiation only (without resonant gold NRs). The fact that 
bacteria grow in the absence of NRs over the course of the experiment leads to small negative LRV values. 
For E. coli (~109 CFU/mL) we measured a LRV of 4.7 after irradiating the bacteria for 30 min with 800 
nm 100 fs laser pulses in the presence of gold NRs (Figure 6B).   
Overall, our data clearly confirm that resonant NPs also enhance the photonic inactivation of gram-
negetive and gram-positive bacteria bacteria and mycoplasma. The maximum inactivation remains lower 
for E. coli and B. subtilis than for mycoplasma, which suggests that larger bacteria with cell walls are 
more robust against the fs-pulsed laser irradiation even in the presence of resonant NP. 
 
Conclusion 
The central physical innovation in this study is the adaptation of the well-established principle of 
plasmonic enhancement of Near-Infrared (NIR) ultrashort pulses to the photonic inactivation of a broad 
range of pathogen species. We validated the efficacy of the plasmonic enhancement scheme for phages, 
mycoplasma and gram-negative and gram-positive bacteria. The plasmonic enhancement facilitated an 
effective photonic inactivation of a broad range of biologically diverse pathogens at an operational 
wavelength of 800 nm. We achieved LRV of > 7 for fX174 and up to 6.7 for A. laidlawii, 3.4 for B. 
subtilis and 4.7 for E. coli using pulsed radiation in the presence of resonant NPs. The plasmonic 
enhancement of photonic inactivation also allowed for a faster treatment of the samples. In the case of the 
bacteria, for instance, we decreased the exposure time from hours to a few tens of minutes and increased 
the treated volume by more than 1 order of magnitude compared to conventional pulsed laser viral 
inactivation methods (15). For fX174 we achieved inactivation within minutes compared to hours for 
conventional photonic inactivation reported in previous studies (18). For membrane-wrapped viruses 
plasmon-enhanced photonic inactivation was even accomplished within tens of seconds (22). We also 
successfully demonstrated in the case of fX174 that the plasmonic enhancement of photonic inactivation 
is compatible with a flow-through mode, which provides new opportunities for improving the throughput 
and scalability of photonic inactivation schemes that are effective against a broad range of pathogens. 
Plasmonic NPs resonant in the NIR made it possible to operate in a wavelength range with minimal 
collateral damage to co-incubated antibodies, which proves the intrinsic value of the techniques to 
selectively inactivate pathogens while retaining the activity of biologics. Biologics are among the fastest 
growing class of therapeutic agents in Public Health (43, 44). As for all pharmaceuticals derived from 
cultured cells, microbial contamination is an integral risks of biologics production (45, 46). Despite 
different upstream clearance steps for starting materials, filtration is currently the only technology that can 
retain potential microbial contaminations without harming the product in monoclonal antibody 
fabrication. Removal especially of virus and mycoplasma pathogens through passive filtration faces a 
series of scientific and technical challenges and remains a crucial step in the manufacturing of biologics. 
As plasmon-enhanced photonic inactivation has been demonstrated to yield LRV > 4 for non-enveloped 
viruses fX174 (this study) as well as enveloped MLV (22), this novel photonic technology provides an 
alternative strategy to overcome these longstanding challenges associated with small viruses and 
mycoplasma and, at the same time, retains efficacy against larger bacteria. We envision that the technology 
can eventually also be translated to patient-related applications, for instance, to fight antibiotic-resistant 
topical infections and sterilize dermal and other acute wounds, etc. that are accessible for NR treatment. 
The urgent need for alternative strategies to combat microbial infections in a time of failing antibiotics 
provides this research additional significance (47). This work underlines the potential of plasmonic NPs 
to enable new “physical” antimicrobial strategies that could in the future complement existing molecular 
strategies. 
 
Materials and Methods 
NR and Bipyramid Synthesis. Tetrachloroauric acid (HAuCl4, ≥ 99%), hexadecyltrimethylammonium 
chloride (CTAC, 25 wt% in water), hexadecyltrimethylammonium bromide (CTAB, ≥ 99%), citric acid 
(≥ 99.5%), sodium borohydride (NaBH4), silver nitrate (AgNO3, ≥ 99%), hydrochloric acid (HCl, 37%), 
L-ascorbic acid (AA, ≥ 99%) were purchased from Sigma-Aldrich. All chemicals were used without 
further purification. Milli-Q water (resistivity 18.2 MΩ·cm at 25 °C) was used in all experiments. Gold 
bipyramids were synthesized and purified as described in the literature (48, 49). Gold NRs were 
synthesized using the seed-mediated growth technique described by Vigderman et al (50). To obtain 
PEGylated NRs, 2.5 µL of 10 mM PEG2 (HS–CH2CH2–(C2H4O)77–N3) were added together with 2.5 µL 
of 10 mM HS-(CH2)11-(CH2CH2O)6OCH2-COOH to 1mL of gold NRs in the presence of 3% v/v of Tween 
20. The samples were incubated overnight and washed by centrifugation and subsequent resuspension. 
Alkyne-functionalized annexinV was cross-linked to the azide functionalized NRs in the presence of 500 
µM ascorbic acid and 100 µM CuSO4 via CuI catalyzed click-reaction (51). The NRs were cleaned again 
through repeated centrifugation and resuspension in DDI water or buffer. The PEGylated bipyramids were 
obtained by following a similar procedure 
 
Set-up of Laser Inactivation. We investigate the photonic inactivation of the different samples via two 
different laser wavelengths, at multiple treatment times for two different modes; batch mode and flow-
through mode. The excitation source employed in this work were fs lasers. We either used a Ti:sapphire 
based laser pulses (800 nm, 1 kHz) with a regenerative amplifier system (Libra-F-1k-HE-110, Coherent, 
CA) with 3 W power that generated 100 fs pulses. Alternatively, we used a Legend Elite Duo (Coherent 
Inc.) Ti-sapphire regenerative amplifier, which produces a continuous train of 35 fs pulses at a repetition 
rate of 1 kHz centered at 800 nm with energies up to 7 mJ per pulse, with the tightest laser spot size of 
approximately 0.9 cm2. A dichroic beam splitter directs half of the laser beam to an optical parametric 
amplifier, or to a frequency doubling crystal. In this arrangement, up to 3 W of average power are available 
at the fundamental and 2.5 W of power in frequency doubled generated light. In batch mode, typically 1.5 
mL of pathogen solution was transferred to quartz cuvette and a magnetic stirrer was used to facilitate the 
interaction of laser beam with pathogens. Virus and bacteria samples were assayed using a plaque-forming 
assay and standard plate count agar method, respectively. An alternative arrangement to test the prospects 
for larger scale processing was investigated in a flow chamber connected to a syringe pump (flow-through 
mode). Briefly, a flow cell of 2 mm depth made of Quartz was connected to a reservoir and a syringe 
pump was used to slowly drive the samples past the incident laser beam, with typical infusion flow rates 
of 2 mL/h and withdraw fusion rate of 100 mL/h. To check against non-uniform exposure in these unstirred 
samples undergoing laminar flow in the 2 mm depth, the syringe pump was operated in both infuse and 
withdraw mode, up to a total of three times. Control samples consist of a sample flowed through the cell 
without any exposure and another sample which held in refrigerator.  
 
fX174 Sample Preparation. fX174 samples (Promega TiterMax fX174 Bacteriophage) with 2 × 1012 
plaque forming unit per mL (pfu/mL) concentration in 0.05 M Sodium Tetraborate were stored at -80°C. 
Then the fX174 virus for our experiments were prepared by serial dilution of stock sample in Sorenson 
buffer (pH 7.3) to the final concentration of 1×106 pfu/mL, and 1×109 pfu/mL. For samples containing 
plasmonic NPs, fX174 with initial titer of 109 pfu/mL combined with around 100-fold excess gold NRs 
to form a sample volume of 1.5 mL  
 
fX174 Plaque Assay. fX174 samples were diluted with Sorenson buffer, and assayed by adding 0.1 mL 
of diluted sample and 0.1 mL of host cell suspension to a test tube. The test tube contains 3 mL of molten 
(46-48 °C) fX174 overlay agar consist of 5 g of NaCl per liter of reagent water, 8.5 g of agar and 10 g of 
tryptone peptone. Then the solution of bacteriophage and host cell was transferred to the fX174 bottom 
plate agar containing 10 g of tryptone peptone, 10 g of agar, and 1 mL of 1 M CaCl2 per liter of reagent 
grade water, 2.5 g of NaCl, 2.5 g of KCl, and then incubated overnight at 37 °C. Then plaques counting 
result is being reported as pfu/mL. Sorenson phosphate buffer, and fX174 overlay and bottom plate agar 
were purchased from Northeast Laboratory Services (Winslow, ME). 
 
B. subtilis Preparation. Glycerol stocks (glycerol: Fisher Scientific BP229-1) of B. subtilis subspecies 
subtilis strain 168 (NCBI accession: NP_000964) were inoculated in liquid 5mL LB cultures (Fisher 
Scientific BP1426-2) and grown overnight (37C, shaking 250rpm, 16 hours). The following day, overnight 
culture was diluted in 45mL of LB broth and grown for another hour (37°C, 250rpm). Bacterial culture 
with initial titers of ~ 109 CFU/mL was then transferred to a 50mL centrifuge tubes (Denville Scientific 
C1060-P) and sent for laser exposure. For samples containing NPs, PEGylated NRs were added to the 
bacterial culture tube to final volume of 1.5 ml which is illuminated for 20 min with 800 nm radiation. 
The NR to bacteria ratio was around 100:1 
 
B. subtilis Colony Counting. Following laser exposure, samples were serially diluted by taking 100 µL 
of the sample and ejecting it in 900 µL LB. This was then briefly vortexed to mix before taking 100 µL of 
the diluted sample and adding it to 900 µL of fresh LB. This was done over seven orders of magnitude. 
100 µL of diluted samples were then plated on LB agar plates (Fisher Scientific BP1425) and grown for 
16 hours at 37°C. Viable colonies were then counted and the dilution factor was used to calculate colony 
forming units per mL (CFU / mL).  
 
A. laidlawii Culture Preparation and Assay. Oleic and palmitic acids were prepared separately in 100% 
ethanol to achieve a concentration of 10 mg/mL each.  Each fatty acid was filter sterilized and stored 
separately. Glucose Hydrolysate Broth (GHB) was prepared with 4% w/v polypeptone, 0.5% w/v Trizma 
Base (2-Amino-2-(hydroxymethyl)-1,3-propanediol), 0.78% glucose, and 0.4% Bovine Serum Albumin 
(BSA) in Milli-Q water.  Oleic acid and palmitic acid were aseptically added to deliver a final 
concentration of 0.002% w/v each.  Glucose Mycoplasma Agar (GMA), Part 1 contained: 2% w/v 
Mycoplasma Broth Base, 0.5% w/v Trizma® Base, 0.78% w/v glucose and ASTM Type 1 water. This 
preparation was sterilized in a validated slow exhaust cycle at a minimum of 121.1 °C.  Sterile GMA Part 
2 contained: 0.78% w/v glucose, 0.4% w/v BSA and ASTM Type 1 water and filter sterilized. All 
components were tempered and aseptically added.  Oleic acid and palmitic acid were aseptically added to 
Sterile GMA Part 2 to deliver a final concentration of 0.002% w/v each. The agar base was tempered and 
aseptically added to the GMA Part 1 and the Sterile GMA Part 2 to arrive at a dispensing temperature of 
43 to 45°C.  
A frozen stock vial of A. laidlawii ATCC 23206™ was rapidly thawed and transferred to GHB broth in 
order to achieve a final concentration of 4% (v/v) inoculum to broth.  Cultures were incubated at 37ºC (± 
2ºC), with 6% (± 1%) CO2 for 22 (± 2) hours. A. laidlawii from a 22 (± 2) hour culture in GHB was diluted 
into Mycoplasma Phosphate Buffer to deliver a minimum final target concentration of 1 x 108 -1 x 109 
CFU/mL. PEGylated NRs was added to the mycoplasma suspension followed by 5 hr incubation at 4 °C. 
Then, 1.5 mL of samples were irradiated with 800nm laser for 30 min. The NR to bacteria ratio was around 
100:1. Samples of the A. laidlawii culture and the A. laidlawii challenge suspension were serially diluted 
in mycoplasma buffer and enumerated using the pour-plate method with GMA agar.  Plates were incubated 
at 37ºC (± 2ºC), with 6% (± 1%) CO2 for 4-7 days. Post-incubation the pour-plates were enumerated.  
 
E. coli Samples Preparation. Glycerol stocks of E. coli strain K-12 substrain MG1655 (NCBI accession: 
U00096) were inoculated in 5mL of liquid LB broth (Fisher Scientific BP1426-2) and grown overnight 
(37C, shaking 250rpm, 16 hours). The following day, overnight culture was expanded by adding the 5mL 
of overnight culture to 45mL of fresh LB broth and incubated (1 hour, 37C, shaking 250rpm). Expanded 
bacterial culture with initial titers of ~ 109 CFU/mL was then transferred to a 50mL centrifuge tube 
(Denville Scientific C1060-P). For E. coli samples containing gold Nano rods, the Nano rods to bacteria 
ratio was around 100:1 to form a sample volume of 1 mL and laser exposed samples were illuminated for 
30 min with 800 nm radiation. 
 
E. coli Viability Assay. Following laser exposure, samples were serially diluted by taking 100 µL of 
laser-exposed bacterial culture and adding it to 900 µL of fresh LB broth. This was then briefly (2-4s) 
vortexed to mix and then serially diluted by taking 100 µL of the diluted culture and adding it to another 
900 µL of fresh LB. This was done over seven orders of magnitude. 100 µL of the diluted samples were 
then plated on LB agar plates (Fisher Scientific BP1425) and grown overnight at 37C. The following day, 
colonies were counted and the order of magnitude of the dilution was used to calculate colony forming 
units of the original, laser-exposed sample. 
 
Log Reduction Value Calculation. The results for the pathogen inactivation assays are reported as the 
LRV, which is a measure of the ability of the treatment processes to inactivate pathogenic microorganisms.  
LRVs are determined by taking the logarithm of the ratio of pathogen concentration in the untreated and 
laser exposed sample (shown in Equ.1).  
  
 
  where CU and CT are the concentration of the untreated and treated samples, respectively. 
 
Statistical Analysis. The Anova test is performed in MATLAB to analyze the variability in the LRV data. 
The notation NS is used to emphasis on non-significant differences between samples while the 
significance level of differences of P < 0.05 are marked with one asterisk (*), and for P < 0.005 with two 
asterisks (**).  
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Fig. 1 The interaction of an ultrafast laser irradiation with plasmonic bipyramids. (A) UV-Vis spectra 
of bipyramids recorded after irradiation of the sample with 800 nm fs laser with 3W power for different 
irradiation time. Control refers to bipyramids without irradiation. TEM image of bipyramids before (B) and 
after irradiation with 35 fs laser pulses for (C) 10 s, (D) 1 min, (E) 10 min and (F) 30 min.  
 
 
 
Fig. 2 Ultrafast laser treatment of viruses in batch mode. (A) Schematic of experimental setup for 
photonic pathogen inactivation in batch mode. The following abbreviation are used; fs: femtosecond, 
BBO: Beta barium borate.  (B) Log fraction of survival for MNV-1 derived from the literature(35) and for 
ϕX174 obtained by us. Our work clearly shows a wavelength dependent difference in the log reduction 
value (LRV) in ϕX174. Even at a high virus titer, an LRV of > 6 was achieved. (C) Demonstration of viral 
inactivation with laser treatment shows consistent LRV of > 4, even for the shortest ~ 1min exposure 
times when exposed with frequency doubled 400nm (Blue). Little or no reduction was detected with 800 
nm laser (Red) radiation, even with incident intensities > 100 GW/cm2. 
 
  
Fig. 3 Plasmon-enhanced treatment of viruses in flow-through mode. (A) Schematic of experimental 
setup for pathogen inactivation in flow-through mode. (B) ϕX174 (V) log-reduction-value in the flow-
through mode demonstrates effective viral inactivation with LRV of > 6 using frequency doubled 400 nm 
laser treatment, which is independent of sample volumes or freezing step after experiments before the 
assay. Laser average power was held constant at 2.5 W and flow rate of 2mL/h (C) LRV measured for 
ϕX174, ϕX174+ PEGylated nanorods (NR), ϕX174+ PEGylated bipyramids (BP) in flow-through mode 
with 2ml/h flow rate when exposed with 800 nm laser.  LRV also obtained for ϕX174+ PEGylated 
nanorods, under similar laser conditions but for flow rate of 100 mL/h.  Laser average power was held 
constant at 3W. 
 
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Characterization of monoclonal antibodies after laser exposure. (A) Cation exchange 
chromatograms, (B) Aggregate and monomer ratios determined by size exclusion chromatography, 
(C) UV-Vis spectra of antibodies recorded after 0-300s fs-laser irradiation with red (left) and blue 
(right) light. 	
 
Fig. 5 Plasmonic enhancement of photonic mycoplasma inactivation. (A) LRV obtained after 30 min 
irradiation of A. laidlawii suspended in Phosphate GHB with pulsed 800 nm laser (Red), frequency 
doubled 400 nm laser (Blue) in the presence and absence of Concanavalin A functionalized nanorods 
(NR*) (B) LRV measured of A. laidlawii (B) suspended in Phosphate GHB in presence or absence of 
PEGylated gold nanorods (NR). Laser irradiation conditions were identical to (a).  
 
 
 
 
Fig. 6 Plasmonic enhancement of photonic inactivation of B. Subtilis and E. Coli. (A) LRV obtained 
after irradiation to a pulsed (35 fs) 800 nm laser with an average power of 3 W for B. subtilis (B) alone 
and B. subtilis + PEGylated nanorods (B+NR). Irradiation time with 100 fs laser at 800 nm was 20 min. 
(B) LRV of E. coli in absence (B) and presence (B+BP) of PEGylated bipyramids. Irradiation time was 30 
min. 
 
 
 
	
